Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8801)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 15, 2019 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gerum S, Jensen AD, Roeder F. Stereotactic body radiation therapy in patients with hepatocellular carcinoma: A mini-review. World J Gastrointest Oncol 2019; 11(5): 367-376 [PMID: 31139307 DOI: 10.4251/wjgo.v11.i5.367] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v11/i5/367.htm |
| Number | Citing Articles |
| 1 |
Aseel Y. Abualnil, Ritesh Kumar, Mridula A. George, Alexander Lalos, Mihir M. Shah, Matthew P. Deek, Salma K. Jabbour. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 173 doi: 10.1016/j.soc.2023.06.012
|
| 2 |
Bardia Bidarmaghz, Marwan Idrees, Yoo Young Lee, Peter Hodgkinson. Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy. BMJ Case Reports 2023; 16(12): e256931 doi: 10.1136/bcr-2023-256931
|
| 3 |
Liang-Cheng Chen, Hon-Yi Lin, Moon-Sing Lee, Wen-Yen Chiou, Li-Wen Huang, Chia-Hui Chew, Feng-Chun Hsu, Shih-Kai Hung. Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center. Tzu Chi Medical Journal 2021; 33(4): 380 doi: 10.4103/tcmj.tcmj_247_20
|
| 4 |
Michael J. Gutman, Lucas M. Serra, Matthew Koshy, Rohan R. Katipally. SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know. Seminars in Interventional Radiology 2024; 41(01): 001 doi: 10.1055/s-0043-1778657
|
| 5 |
Anirut Watcharawipha, Somvilai Chakrabandhu, Anupong Kongsa, Damrongsak Tippanya, Imjai Chitapanarux. Plan quality analysis of stereotactic ablative body radiotherapy treatment planning in liver tumor. Journal of Applied Clinical Medical Physics 2023; 24(7) doi: 10.1002/acm2.13948
|
| 6 |
Tang‐yu Lam, Wai‐man Wong, Ching‐ching Lee, Chin‐cheung Cheung. Transarterial chemoembolisation plus stereotactic body radiotherapy as conversion therapy for large right lobe hepatocecullar carcinoma. Surgical Practice 2021; 25(4): 211 doi: 10.1111/1744-1633.12530
|
| 7 |
Stephen F Mee, Daniel F Polan, Yuni K Dewaraja, Kyle C Cuneo, Joseph J Gemmete, Joseph R Evans, Theodore S Lawrence, Janell S Dow, Justin K Mikell. Stereotactic body radiation therapy (SBRT) following Yttrium-90 (90Y) selective internal radiation therapy (SIRT): a feasibility planning study using 90Y delivered dose. Physics in Medicine & Biology 2023; 68(6): 065003 doi: 10.1088/1361-6560/acbbb5
|
| 8 |
Kyle R. Padgett, Garrett Simpson, David Asher, Lorraine Portelance, Elizabeth Bossart, Nesrin Dogan. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers. Physica Medica 2020; 77: 54 doi: 10.1016/j.ejmp.2020.07.027
|
| 9 |
Sirisha Tadimalla, Wei Wang, Annette Haworth. Role of Functional MRI in Liver SBRT: Current Use and Future Directions. Cancers 2022; 14(23): 5860 doi: 10.3390/cancers14235860
|
| 10 |
Feiqian Wang, Kazushi Numata, Atsuya Takeda, Katsuaki Ogushi, Hiroyuki Fukuda, Koji Hara, Makoto Chuma, Takahisa Eriguchi, Yuichirou Tsurugai, Shin Maeda, Stephen Chun. Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 hepatocellular carcinoma. PLOS ONE 2021; 16(1): e0245076 doi: 10.1371/journal.pone.0245076
|
| 11 |
Rong Chen, Yanli An, Muhao Xu, Calogero Casà. Prognostic difference between surgery and external radiation in patients with stage I liver cancer based on competitive risk model and conditional survival rate. PLOS ONE 2024; 19(3): e0298014 doi: 10.1371/journal.pone.0298014
|
| 12 |
Hanna Rahbek Mortensen, Gerda Elisabeth Villadsen, Esben Schjødt Worm, Britta Weber. Survival and morbidity following stereotactic radiotherapy of hepatocellular carcinoma: a ten-year, single institution experience. Scandinavian Journal of Gastroenterology 2021; 56(3): 259 doi: 10.1080/00365521.2020.1869822
|
| 13 |
Keara English, N. Patrik Brodin, Viswanathan Shankar, Shaoyu Zhu, Nitin Ohri, Yosef S. Golowa, Jacob Cynamon, Sarah Bellemare, Andreas Kaubisch, Milan Kinkhabwala, Shalom Kalnicki, Madhur K. Garg, Chandan Guha, Rafi Kabarriti. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma. JAMA Network Open 2020; 3(11): e2023942 doi: 10.1001/jamanetworkopen.2020.23942
|
| 14 |
Franziska Walter, Lukas Nierer, Maya Rottler, Anna Sophie Duque, Helmut Weingandt, Justus Well, Roel Shpani, Guillaume Landry, Max Seidensticker, Florian Streitparth, Jens Ricke, Claus Belka, Stefanie Corradini. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. Radiation Oncology 2021; 16(1) doi: 10.1186/s13014-021-01812-7
|
| 15 |
Shu Zhang, Weiyi Zhan, Ni Zeng, Jiangping Yang, Maoqi Xiong, Wenjun Liao, Nianyong Chen, Jianghong Xiao. Dosimetric comparison in sparing normal tissue dosage by using auto-SBRT planning in oligo liver tumors. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1273042
|
| 16 |
Qiao Ying Pauline Chan, Deanna Morrow, David Lurie. Canine primary liver tumors treated with stereotactic body radiation therapy: A case series. Veterinary Radiology & Ultrasound 2024; 65(2): 121 doi: 10.1111/vru.13336
|
| 17 |
Kimberly L. Shampain, Caitlin E. Hackett, Sohrab Towfighi, Anum Aslam, William R. Masch, Alison C. Harris, Silvia D. Chang, Kanika Khanna, Vivek Mendiratta, Ahmed M. Gabr, Dawn Owen, Mishal Mendiratta-Lala. SBRT for HCC: Overview of technique and treatment response assessment. Abdominal Radiology 2021; 46(8): 3615 doi: 10.1007/s00261-021-03107-7
|
| 18 |
Shisuo Du, Genwen Chen, Baoying Yuan, Yong Hu, Ping Yang, Yixing Chen, Qianqian Zhao, Jian Zhou, Jia Fan, Zhaochong Zeng. DNA sensing and associated type 1 interferon signaling contributes to progression of radiation-induced liver injury. Cellular & Molecular Immunology 2021; 18(7): 1718 doi: 10.1038/s41423-020-0395-x
|
| 19 |
Sabine Gerum, Christian Heinz, Claus Belka, Franziska Walter, Philipp Marius Paprottka, Enrico N De Toni, Falk Roeder. Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting. Strahlentherapie und Onkologie 2020; 196(4): 334 doi: 10.1007/s00066-019-01540-8
|
| 20 |
Clelia Donisi, Marco Puzzoni, Pina Ziranu, Eleonora Lai, Stefano Mariani, Giorgio Saba, Valentino Impera, Marco Dubois, Mara Persano, Marco Migliari, Andrea Pretta, Nicole Liscia, Giorgio Astara, Mario Scartozzi. Immune Checkpoint Inhibitors in the Treatment of HCC. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.601240
|
| 21 |
Xuan-Yu Gu, Jin-Long Huo, Zhi-Yong Yu, Ji-Chang Jiang, Ya-Xuan Xu, Li-Jin Zhao. Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects. Oncologie 2024; 26(1): 9 doi: 10.1515/oncologie-2023-0412
|